Receptors for 1,25-dihydroxyvitamin D3 in gynecologic neoplasms

Gynecologic Oncology

Volumn 44, Issue 2, 1992, Pages 131-136

  Saunders, Dwight E ^a,b   Christensen, Carl ^a,b   Lawrence, W Dwayne ^b   Malviya, Vinay K ^b   Malone, John M ^b   Williams, James R ^a,b   Deppe, Gunter ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

24,25 DIHYDROXYCOLECALCIFEROL; CALCIFEDIOL; CALCITRIOL; CALCITRIOL RECEPTOR; ESTRADIOL;

ARTICLE; CARCINOMA CELL; CELL GROWTH; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENDOMETRIUM TUMOR; FEMALE; GROWTH INHIBITION; GYNECOLOGIC CANCER; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; UTERINE CERVIX TUMOR; UTERUS SARCOMA;

CALCITRIOL; FEMALE; HUMAN; OVARIAN NEOPLASMS; RECEPTORS, CALCITRIOL; RECEPTORS, STEROID; SARCOMA; UTERINE NEOPLASMS;

EID: 0026508959     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/0090-8258(92)90028-H     Document Type: Article

References (35)

1. Radiation therapy in the treatment of carcinoma of the ovary
2. The use of a human endometrial carcinoma cell line (RL-95) for in vitro testing of chemotherapeutic agents
3. Chemotherapy of ovarian cancer
4. Second-line chemotherapy for ovarian cancer
5. 3
6. Vitamin D receptors: Nature and function
7. Vitamin D and its relevance to cancer
8. 3 receptors: Gene regulation and genetic circuitry
9. The vitamin D endocrine system: Steroid metabolism, hormone receptors, and biological response (calcium binding proteins)
10. 3): Implications for future pharmacological use
11. 3 in cultured chick kidney cells
12. A superfamily of potentially oncogenic hormone receptors
13. 1,25-Dihydroxyvitamin-D receptor in breast cancer cells
14. 3 and malignant melanoma: The presence of receptors and inhibition of cell growth in culture
15. Specific binding of 1,25-dihydroxycholecalciferol in human medullary thyroid carcinoma
16. 3
17. 3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor
18. Vitamin D and retinoblastoma. The presence of receptors and inhibition of growth in vitro
19. 3
20. 3 prolong survival time of mice inoculated with myeloid leukemia cells
21. 3
22. 3 and retinoic acid in acute leukemia and myelodysplastic syndromes
23. Responsiveness of human carcinoma cells of gynecologic origin to 1,25-dihydroxycholecalciferol
24. Prognostic factors in primary breast cancer
25. Relation of tumor content of estrogen and progesterone receptors with response of patient to endocrine therapy
26. The attraction of proteins for small molecules and ions
27. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR3) with androgen and estrogen receptors
28. Preparing nuclei from cells in monolayer cultures suitable for counting and for following synchronized cells through the cell cycle
29. 3 not requiring high performance liquid chromatography: Application to clinical studies
30. Verhoeff's query: Is vitamin D effective against retinoblastoma?
31. 3 one of the endogenous substances regulating calcium metabolism
32. 3: Preferential activity in inducing differentiation of HL-60 human leukemia cells in vitro
33. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation
34. Analogs of the hormonal form of vitamin D and their possible use in leukemia
35. 3 prolongs survival time of leukemic mice